BRPI1013904A2 - método e composição para tratar cetoacidose diabética - Google Patents
método e composição para tratar cetoacidose diabéticaInfo
- Publication number
- BRPI1013904A2 BRPI1013904A2 BRPI1013904A BRPI1013904A BRPI1013904A2 BR PI1013904 A2 BRPI1013904 A2 BR PI1013904A2 BR PI1013904 A BRPI1013904 A BR PI1013904A BR PI1013904 A BRPI1013904 A BR PI1013904A BR PI1013904 A2 BRPI1013904 A2 BR PI1013904A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- treating diabetic
- diabetic ketoacidosis
- ketoacidosis
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17428309P | 2009-04-30 | 2009-04-30 | |
PCT/US2010/033083 WO2010127197A2 (en) | 2009-04-30 | 2010-04-30 | Method and composition for treating diabetic ketoacidosis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1013904A2 true BRPI1013904A2 (pt) | 2016-07-19 |
Family
ID=43032791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1013904A BRPI1013904A2 (pt) | 2009-04-30 | 2010-04-30 | método e composição para tratar cetoacidose diabética |
Country Status (10)
Country | Link |
---|---|
US (1) | US8980874B2 (pt) |
EP (1) | EP2424530B1 (pt) |
JP (1) | JP5536198B2 (pt) |
CN (1) | CN102548553B (pt) |
AU (1) | AU2010242930B2 (pt) |
BR (1) | BRPI1013904A2 (pt) |
CA (1) | CA2759795C (pt) |
ES (1) | ES2562957T3 (pt) |
PL (1) | PL2424530T3 (pt) |
WO (1) | WO2010127197A2 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2424529T3 (pl) | 2009-04-30 | 2017-06-30 | Midwestern University | Nowe postępowania terapeutyczne z zastosowaniem centakwiny |
KR20210011928A (ko) * | 2018-04-20 | 2021-02-02 | 버지니아 테크 인터렉추얼 프라퍼티스, 인크. | 미토콘드리아 언커플러로서 유용한 옥사디아졸로피라진 및 옥사디아졸로피리딘 |
CN118203574A (zh) | 2019-10-30 | 2024-06-18 | 珀弗斯治疗股份有限公司 | 使用内皮素受体拮抗剂治疗眼部疾病 |
AU2021217358A1 (en) | 2020-02-06 | 2022-09-08 | Perfuse Therapeutics, Inc. | Compositions for treatment of ocular diseases |
JP2023517927A (ja) * | 2020-03-11 | 2023-04-27 | アモーフィカル リミテッド. | アシドーシスの治療のための非晶質炭酸カルシウム |
CA3218251A1 (en) | 2021-04-30 | 2022-11-03 | Perfuse Therapeutics, Inc. | Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases |
EP4329810A4 (en) * | 2021-04-30 | 2025-02-26 | Perfuse Therapeutics Inc | TREATMENT OF EYE DISEASES WITH ENDOTHELIN RECEPTOR ANTAGONISTS |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922681A (en) | 1992-09-14 | 1999-07-13 | Warner-Lambert Company | Endothelin antagonists |
US20070293429A1 (en) * | 2004-10-08 | 2007-12-20 | Therapei Pharmaceuticals, Inc. | Vasoactive Intestinal Polypeptide Compositions |
WO2008043102A2 (en) | 2006-10-06 | 2008-04-10 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide compositions |
CA2697057A1 (en) * | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
-
2010
- 2010-04-30 BR BRPI1013904A patent/BRPI1013904A2/pt not_active Application Discontinuation
- 2010-04-30 US US13/266,314 patent/US8980874B2/en not_active Expired - Fee Related
- 2010-04-30 EP EP10770393.6A patent/EP2424530B1/en active Active
- 2010-04-30 PL PL10770393T patent/PL2424530T3/pl unknown
- 2010-04-30 CA CA2759795A patent/CA2759795C/en active Active
- 2010-04-30 JP JP2012508762A patent/JP5536198B2/ja active Active
- 2010-04-30 AU AU2010242930A patent/AU2010242930B2/en active Active
- 2010-04-30 WO PCT/US2010/033083 patent/WO2010127197A2/en active Application Filing
- 2010-04-30 CN CN201080030271.1A patent/CN102548553B/zh active Active
- 2010-04-30 ES ES10770393.6T patent/ES2562957T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP2424530A2 (en) | 2012-03-07 |
CA2759795A1 (en) | 2010-11-04 |
CN102548553A (zh) | 2012-07-04 |
ES2562957T3 (es) | 2016-03-09 |
US20120070513A1 (en) | 2012-03-22 |
US8980874B2 (en) | 2015-03-17 |
CN102548553B (zh) | 2016-07-13 |
PL2424530T3 (pl) | 2016-07-29 |
WO2010127197A2 (en) | 2010-11-04 |
CA2759795C (en) | 2016-11-29 |
AU2010242930B2 (en) | 2015-10-08 |
JP2012525436A (ja) | 2012-10-22 |
EP2424530B1 (en) | 2015-12-16 |
JP5536198B2 (ja) | 2014-07-02 |
EP2424530A4 (en) | 2012-09-12 |
WO2010127197A3 (en) | 2011-03-31 |
AU2010242930A1 (en) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249446A1 (zh) | 用於治療乳糜瀉的組合物和方法 | |
BRPI1011325A2 (pt) | composições e métodos para o tratamento de inflamação | |
BR112014014234A2 (pt) | composição não colorante para tratar as fibras queratínicas e método para tratar as fibras queratínicas | |
BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
BRPI1013878A2 (pt) | método para tratar distúrbios metabólicos, e, composto | |
BRPI0920326A2 (pt) | composição e método para tratamento da síndrome do olho ressecado | |
BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
BRPI1006145A2 (pt) | "composição e método para tratamento de diabetes". | |
BR112012028514A2 (pt) | composição para o tratamento da água residual e processo para o tratamento de água residual | |
BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
BRPI0911077A2 (pt) | método para tratamento de biomassa | |
BRPI1008617A2 (pt) | método e aparelho para lipoaspiração | |
BRPI1013361A2 (pt) | método para evitar e tratar hipermeabilidade. | |
BR112013004456A2 (pt) | composição para tratamento de planta, e, método para o tratamento de plantas | |
BRPI1007600A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
BRPI1006238A2 (pt) | método para o tratamento pesticida de plantações e composição | |
BRPI0917496A2 (pt) | metodo para realizacao de adaptacao de conteudos e servidor de adaptacao de conteudos | |
BRPI1008484A2 (pt) | codificador, decodificador e método para os mesmos | |
BRPI1008326A2 (pt) | Composições e métodos para controlar nanatódeos | |
BRPI1007561A2 (pt) | método para revitalizar uma composição contendo betume, e, composição | |
BR112012006437A2 (pt) | composições e métodos para tratamento do diabetes e outros distúrbios | |
BRPI1013927A2 (pt) | métodos e composições para o tratamento de lúpus | |
BRPI0923534A2 (pt) | composição e método para tratamento de doenças de pele | |
BRPI1011425A2 (pt) | processo e composição para tratar superfície metálicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07E | Notice of approval relating to section 229 industrial property law | ||
B06T | Formal requirements before examination | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal | ||
B12B | Appeal: appeal against refusal |